• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Targeting autophagy in cancer stem cells as an anticancer therapy" [Canc. Lett. 393 (2017) 33-39].

作者信息

Lei Yuanyuan, Zhang Dan, Yu Jin, Dong Hui, Zhang Jianwei, Yang Shiming

机构信息

Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.

Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.

出版信息

Cancer Lett. 2018 Mar 1;416:149. doi: 10.1016/j.canlet.2017.12.027. Epub 2018 Jan 4.

DOI:10.1016/j.canlet.2017.12.027
PMID:29307478
Abstract
摘要

相似文献

1
Corrigendum to "Targeting autophagy in cancer stem cells as an anticancer therapy" [Canc. Lett. 393 (2017) 33-39].
Cancer Lett. 2018 Mar 1;416:149. doi: 10.1016/j.canlet.2017.12.027. Epub 2018 Jan 4.
2
Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173].《“靶向低密度脂蛋白受体相关蛋白8抑制三阴性乳腺癌中的乳腺癌干细胞”的勘误》[《癌症快报》438卷（2018年12月1日）165 - 173页]
Cancer Lett. 2020 Jun 28;480:51. doi: 10.1016/j.canlet.2020.01.013. Epub 2020 Mar 27.
3
Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].对“人参炔醇，一种天然的热休克蛋白90抑制剂，有效靶向肺癌干细胞和非干细胞”[《癌症快报》412（2018）297 - 307]的勘误
Cancer Lett. 2018 Jun 28;424:136. doi: 10.1016/j.canlet.2018.03.023. Epub 2018 Mar 21.
4
Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
Cancer Lett. 2018 Apr 28;420:260. doi: 10.1016/j.canlet.2018.01.073. Epub 2018 Feb 21.
5
Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].《AGBL2通过IRGM调节的自噬和增强的极光激酶A活性促进肝癌细胞生长》[《癌症通讯》414(2018)71 - 80]的勘误
Cancer Lett. 2022 Jul 28;539:215700. doi: 10.1016/j.canlet.2022.215700. Epub 2022 May 4.
6
Corrigendum to "Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells" [Canc. Lett. 466 (2019) 1-12].《胶质母细胞瘤细胞外囊泡诱导神经干细胞的促肿瘤转化》[《癌症通讯》466卷（2019年）1 - 12页]勘误
Cancer Lett. 2021 Feb 1;498:245-246. doi: 10.1016/j.canlet.2020.10.025. Epub 2020 Oct 23.
7
Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Canc. Lett. 410 (2017) 68-81].《长链非编码RNA HOTTIP通过调控HOXA9调节人胰腺癌干细胞特性》[《癌症通讯》410(2017)68 - 81]的勘误
Cancer Lett. 2022 Oct 1;545:215836. doi: 10.1016/j.canlet.2022.215836. Epub 2022 Aug 5.
8
Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134].
Cancer Lett. 2022 Jul 28;539:215695. doi: 10.1016/j.canlet.2022.215695. Epub 2022 Apr 29.
9
Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft' [Canc. Lett. 330 (2013) 22-32].《“GANT-61抑制体外培养及NOD/SCID/IL2Rγ基因敲除小鼠异种移植模型中胰腺癌干细胞生长”的勘误》[《癌症快报》330 (2013) 22 - 32]
Cancer Lett. 2021 Dec 1;522:282. doi: 10.1016/j.canlet.2021.07.028. Epub 2021 Sep 24.
10
Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215].《巨噬细胞表达的CD51通过TGF-β1/smad2/3轴促进胰腺癌中的癌症干细胞特性》的勘误[《癌症快报》459(2019)204 - 215]
Cancer Lett. 2022 Nov 1;548:215897. doi: 10.1016/j.canlet.2022.215897. Epub 2022 Aug 30.

引用本文的文献

1
Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study.评估PINK1蛋白表达作为结直肠癌辅助化疗疗效预测标志物的研究：一项回顾性研究
BMC Gastroenterol. 2025 Aug 13;25(1):582. doi: 10.1186/s12876-025-04197-z.